CEO Paul Josephs told investors at a KeyBanc conference that the company has completed its transition into a “standalone CDMO ...
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company advancing a pipeline of innovative inflammation and immunology therapeutics, and the owner of Scinai Biopharma Services Ltd., ...
BOCA RATON, Fla.-- (BUSINESS WIRE)--March 19, 2026-- ...
BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...
First CDMO Project to Utilize In-house AI Tools for Discovery of Plant Cell Targets for the Botanical Synthesis Process Rehovot, Israel--(Newsfile Corp. - May 21, 2025) - BioHarvest Sciences Inc.
SAN DIEGO and GAINESVILLE, Ga., April 05, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (SCTL) (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO), today ...
The global vaccine Contract Development and Manufacturing Organization (CDMO) market is projected to expand at a compound annual growth rate of approximately 8% over the next five years. Market growth ...
Activities will be Conducted at Societal CDMO’s San Diego Facility and Span Analytic Method Transfer, Process Development, and CGMP Manufacturing Societal CDMO: Bringing Science to Society. For more ...
For the second time in 16 months, Massachusetts biotech Agenus is reorganizing after failing to gain traction with the FDA on its PD-1 candidate balstilimab. Last week, the immuno-oncology specialist ...
The global biologics CDMO market is projected to experience strong growth at a rate of nearly 14–16% over the next five years, driven by rapid expansion of the biopharmaceutical industry. Increasing ...
Over the next 5 years, Gland Pharma plans to invest approximately Rs 20 bn in capex, primarily towards BFS and ophthalmic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results